[ Usage de cannabis et souffrance psychique chez les patients schizophrènes: Étude exploratoire du raisonnement clinique chez 61 patients hospitalisés à l’Hôpital Psychiatrique Arrazi, Maroc ]
Volume 36, Issue 2, May 2022, Pages 377–385
Laila Essfioui1
1 Doctorante en psychopathologie et psychologie clinique, Université Mohammed V, Faculté des Lettres et des Sciences Humaines, Rabat, Morocco
Original language: French
Copyright © 2022 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The links between cannabis and psychotic disorders are old. Indeed, several studies have shown a strong association between cannabis and schizophrenia.Objective - Our research aims to focus on the function of cannabis consumption which may express polymorphic psychic suffering among schizophrenic patients.Method - A qualitative and quantitative study was conducted among 61 schizophrenic patients. And the clinical study.Results - Static analysis and study case have showen that cannabis is the principal consumed substance after tobacco. In our population, 82% are cannabis users, 58% consume it regularly and 80% also consume other psychoactive substances (alcohol, psychotropics).It appears that schizophrenic is characterized by a set of parameters such as: the early start of consumption from adolescence, in particular the early age of first contact with cannabis, the vulnerable personality, the anxiety, dysfunctional environment. The use of the questionnaire showed that 58% of cannabis consumers say they smoke cannabis to alleviate psychological suffering.Conclusion - Subjects suffering froms chizophrenia hospitalized in the Arrazi psychiatric hospital are particularly vulnerable to cannabis consumption. It is not only used according to a more or less manifest need of the subject, but also as an attempt to defend anesthesia and to avoid psychic suffering in a form of self-medication.
Author Keywords: Schizophrenia, Cannabis, Self-medication, Vulnerability, Psychological suffering.
Volume 36, Issue 2, May 2022, Pages 377–385
Laila Essfioui1
1 Doctorante en psychopathologie et psychologie clinique, Université Mohammed V, Faculté des Lettres et des Sciences Humaines, Rabat, Morocco
Original language: French
Copyright © 2022 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
The links between cannabis and psychotic disorders are old. Indeed, several studies have shown a strong association between cannabis and schizophrenia.Objective - Our research aims to focus on the function of cannabis consumption which may express polymorphic psychic suffering among schizophrenic patients.Method - A qualitative and quantitative study was conducted among 61 schizophrenic patients. And the clinical study.Results - Static analysis and study case have showen that cannabis is the principal consumed substance after tobacco. In our population, 82% are cannabis users, 58% consume it regularly and 80% also consume other psychoactive substances (alcohol, psychotropics).It appears that schizophrenic is characterized by a set of parameters such as: the early start of consumption from adolescence, in particular the early age of first contact with cannabis, the vulnerable personality, the anxiety, dysfunctional environment. The use of the questionnaire showed that 58% of cannabis consumers say they smoke cannabis to alleviate psychological suffering.Conclusion - Subjects suffering froms chizophrenia hospitalized in the Arrazi psychiatric hospital are particularly vulnerable to cannabis consumption. It is not only used according to a more or less manifest need of the subject, but also as an attempt to defend anesthesia and to avoid psychic suffering in a form of self-medication.
Author Keywords: Schizophrenia, Cannabis, Self-medication, Vulnerability, Psychological suffering.
Abstract: (french)
Les liens entre cannabis et troubles psychotiques sont anciens, plusieurs études ont montré la présence d’une forte association entre cannabis et schizophrénie.Objectif - Notre étude a pour but de mettre l’accent sur la fonction de la consommation de cannabis qui pourrait exprimer de façon polymorphe la souffrance psychique chez les schizophrènes.Méthode - Une étude quantitative et qualitative a été menée auprès de 61 patients schizophrènes, avec une étude clinique.Résultats - L’analyse statique et l’étude des cas ont démontré que le cannabis est la principale substance consommée après le tabac. Dans notre population, 82% sont des consommateurs du cannabis, 58% le consomment régulièrement et 80% consomment, en plus, d’autres substances psychoactives (alcool, psychotropes). Il s’avère aussi que le schizophrène se singularise par un ensemble de paramètres comme: le début anticipé de la première consommation dès l’adolescence, la vulnérabilité de la personnalité, l’anxiété et l’appartenance à un environnement mal sain. L’utilisation du questionnaire a montré que 58% des consommateurs de cannabis disent fumer du cannabis pour atténuer une souffrance psychique.Conclusion - Les sujets schizophrènes hospitalisés dans l’hôpital psychiatrique Arrazi sont particulièrement vulnérables à la consommation du cannabis. Il est non seulement utilisé en fonction d’un besoin plus ou moins manifeste du sujet, mais aussi comme une tentative de défense d’anesthésie et d’évitement de la souffrance psychique dans une forme d’automédication.
Author Keywords: Schizophrénie, Cannabis, Automédication, Vulnérabilité, Souffrance psychique.
How to Cite this Article
Laila Essfioui, “Use of cannabis and psychic suffering among schizophrenic patients: Exploratory study of clinical reasoning of 61 patients hospitalized at Arrazi Psychiatric Hospital, Morocco,” International Journal of Innovation and Applied Studies, vol. 36, no. 2, pp. 377–385, May 2022.
